344 related articles for article (PubMed ID: 32814635)
21. Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.
Barnkob MB; Pottegård A; Støvring H; Haunstrup TM; Homburg K; Larsen R; Hansen MB; Titlestad K; Aagaard B; Møller BK; Barington T
Blood Adv; 2020 Oct; 4(20):4990-4993. PubMed ID: 33057631
[TBL] [Abstract][Full Text] [Related]
22. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)?
Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N
Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449
[No Abstract] [Full Text] [Related]
23. SARS-CoV-2 and Stroke in a New York Healthcare System.
Yaghi S; Ishida K; Torres J; Mac Grory B; Raz E; Humbert K; Henninger N; Trivedi T; Lillemoe K; Alam S; Sanger M; Kim S; Scher E; Dehkharghani S; Wachs M; Tanweer O; Volpicelli F; Bosworth B; Lord A; Frontera J
Stroke; 2020 Jul; 51(7):2002-2011. PubMed ID: 32432996
[TBL] [Abstract][Full Text] [Related]
24. Viral infections and atherothrombosis: Another caution in the wake of COVID-19?
Pereira MP; Lima EG; Serrano Junior CV
Rev Assoc Med Bras (1992); 2020 Mar; 66(3):366-369. PubMed ID: 32520159
[No Abstract] [Full Text] [Related]
25. Arterial thrombotic complications in hospitalized patients with COVID-19.
Rey JR; Caro-Codón J; Poveda Pineda D; Merino JL; Iniesta ÁM; López-Sendón JL;
Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):769-771. PubMed ID: 32499015
[No Abstract] [Full Text] [Related]
26. Peripheral Blood Examination Findings in SARS-CoV-2 Infection.
Nazarullah A; Liang C; Villarreal A; Higgins RA; Mais DD
Am J Clin Pathol; 2020 Aug; 154(3):319-329. PubMed ID: 32756872
[TBL] [Abstract][Full Text] [Related]
27. COVID-19-associated aortic arch thrombus.
Mosbahi S; Heinisch PP; Schoenhoff FS; Berger DC
Eur J Cardiothorac Surg; 2020 Oct; 58(4):870. PubMed ID: 32820319
[No Abstract] [Full Text] [Related]
28. ABO blood group system is associated with COVID-19 mortality: An epidemiological investigation in the Indian population.
Padhi S; Suvankar S; Dash D; Panda VK; Pati A; Panigrahi J; Panda AK
Transfus Clin Biol; 2020 Nov; 27(4):253-258. PubMed ID: 32987167
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary Embolism, Pulmonary Microvascular Thrombosis, or Both in COVID-19?
Páramo JA
Clin Appl Thromb Hemost; 2020; 26():1076029620933953. PubMed ID: 32697603
[No Abstract] [Full Text] [Related]
30. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
[TBL] [Abstract][Full Text] [Related]
31. Coagulation Dysfunction.
Fei Y; Tang N; Liu H; Cao W
Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
[TBL] [Abstract][Full Text] [Related]
32. The effect of abo and rh blood group antigens on admission to intensive care unit and mortality in patients with COVID-19 infection.
Yaylacı S; Dheir H; İşsever K; Genc AB; Şenocak D; Kocayigit H; Guclu E; Suner K; Ekerbicer H; Koroglu M
Rev Assoc Med Bras (1992); 2020; 66Suppl 2(Suppl 2):86-90. PubMed ID: 32965363
[TBL] [Abstract][Full Text] [Related]
33. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis.
Wu BB; Gu DZ; Yu JN; Yang J; Shen WQ
Infect Genet Evol; 2020 Oct; 84():104485. PubMed ID: 32739464
[TBL] [Abstract][Full Text] [Related]
34. Neutrophils and Contact Activation of Coagulation as Potential Drivers of COVID-19.
Busch MH; Timmermans SAMEG; Nagy M; Visser M; Huckriede J; Aendekerk JP; de Vries F; Potjewijd J; Jallah B; Ysermans R; Oude Lashof AML; Breedveld PH; van de Poll MCG; van de Horst ICC; van Bussel BCT; Theunissen ROMFIH; Spronk HMH; Damoiseaux JGMC; Ten Cate H; Nicolaes GAF; Reutelingsperger CP; van Paassen P
Circulation; 2020 Nov; 142(18):1787-1790. PubMed ID: 32946302
[No Abstract] [Full Text] [Related]
35. Self-limited gastrointestinal bleeding in COVID-19.
Barrett LF; Lo KB; Stanek SR; Walter JW
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):e77-e80. PubMed ID: 32753264
[No Abstract] [Full Text] [Related]
36. Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Horowitz NA; Brenner B
Semin Thromb Hemost; 2020 Oct; 46(7):785-788. PubMed ID: 32785920
[No Abstract] [Full Text] [Related]
37. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 coagulopathy: an evolving story.
The Lancet Haematology
Lancet Haematol; 2020 Jun; 7(6):e425. PubMed ID: 32470428
[No Abstract] [Full Text] [Related]
39. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
[No Abstract] [Full Text] [Related]
40. [Management of the thrombotic risk associated with COVID-19: what is the role of the hemostasis laboratory?].
Hardy M; Douxfils J; Dogné JM; Lessire S; Chatelain B; Testa S; Gouin-Thibault I; Gruel Y; Lecompte T; Mullier F
Ann Biol Clin (Paris); 2020 Oct; 78(5):471-481. PubMed ID: 33026344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
